Security key
74907L409
Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (QNRX)
CUSIP: 74907L409
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, no par value per share
- Total 13F shares
- 439
- Total 13F value
- $2,125
- Share change
- -1,281
- SEC-reported price per share
- $4.84
- Number of holders
- 1
- Value change
- -$6,201
- Number of sells
- 1
- Shares outstanding
- 70,007,000
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
QNRX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Quoin Pharmaceuticals, Ltd. SEC filings
Quoin Pharmaceuticals, Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74907L409
Recent filing periods:
Ownership snapshot
Top reported holders of QNRX - Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Stonepine Capital Managem...
Comparable rows
15/15
Latest evidence
26 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: Ikarian Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
13%
Stonepine Capital Management, LLC
11%
Woodline Partners LP
9.5%
Resolute Capital Asset Partners LLC
8.5%
INTEGRATED CORE STRATEGIES (US) LLC
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
13F
Company
|
13%
|
$3,052,472
211,538 shares
|
$0 | 31 Jan 2026 |
| Stonepine Capital Management, LLC |
3/4/5
13D/G
13F
10%+ Owner · Company
|
11%
from 13D/G
|
$47,201,973
3,271,100 shares
|
— | 26 Mar 2026 |
| Woodline Partners LP |
13D/G
13F
Company
|
9.5%
|
$38,298,838
2,785,370 shares
|
$0 | 31 Dec 2025 |
| Resolute Capital Asset Partners LLC |
13D/G
|
8.5%
|
$671,000
50,000 shares
|
$0 | 10 Oct 2025 |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
5.5%
|
$22,755,775
3,850,385 shares
|
+$7,279,879 | 26 May 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$7,049,313
1,081,183 shares
|
$0 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
439
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
20
Q2 2026 holders
1
Holder diff
-19
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend